0001179110-12-008025.txt : 20120508 0001179110-12-008025.hdr.sgml : 20120508 20120508164702 ACCESSION NUMBER: 0001179110-12-008025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120507 FILED AS OF DATE: 20120508 DATE AS OF CHANGE: 20120508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELDMAN MICHEL J CENTRAL INDEX KEY: 0001236488 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 12822013 MAIL ADDRESS: STREET 1: 626 HOMEWOOD AVENUE STREET 2: #107 CITY: HIGHLAND PARK STATE: IL ZIP: 60035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0305 4 2012-05-07 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001236488 FELDMAN MICHEL J 626 HOMEWOOD AVENUE #107 HIGHLAND PARK IL 60035 1 0 0 0 Common Stock, par value $0.0033 2012-05-07 4 M 0 20000 36.57 A 33177 D Common Stock, par value $0.0033 2012-05-07 4 S 0 20000 73.77 D 13177 D Common Stock, par value $0.0033 1000 I by spouse Non-Qualified Options to Purchase Common Stock 36.57 2012-05-07 4 M 0 20000 0 D 2006-05-17 2014-05-17 Common Stock, par value $0.0033 20000 10000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.75 to $73.89, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/MICHEL J. FELDMAN 2012-05-08